Wednesday, February 11, 2026

Canada’s Politics and Government News Source Since 1989

Wednesday, February 11, 2026 | Latest Paper

Pharma

The regulation of drug prices elsewhere is a long-standing trade policy irritant for the U.S., writes Liam MacDonald. Photograph courtesy of Pixabay
News | BY TESSIE SANCI | December 22, 2025
Guillaume Couillard, director general at the Patented Medicine Prices Review Board, says that the high number of investigations in 2023 and 2024 are due to one approach set by the 2022 temporary guidelines, which will be replaced by permanent guidance on Jan. 1, 2026. Photograph courtesy of the Patented Medicine Prices Review Board
News | BY TESSIE SANCI | December 22, 2025
News | BY TESSIE SANCI | December 22, 2025
Guillaume Couillard, director general at the Patented Medicine Prices Review Board, says that the high number of investigations in 2023 and 2024 are due to one approach set by the 2022 temporary guidelines, which will be replaced by permanent guidance on Jan. 1, 2026. Photograph courtesy of the Patented Medicine Prices Review Board
News | BY TESSIE SANCI | December 1, 2025
Health Minister Marjorie Michel has not produced any bilateral agreements since joining cabinet this past May even though her government has repeatedly committed to protecting pharmacare. The Hill Times photograph by Andrew Meade
News | BY TESSIE SANCI | December 1, 2025
News | BY TESSIE SANCI | December 1, 2025
Health Minister Marjorie Michel has not produced any bilateral agreements since joining cabinet this past May even though her government has repeatedly committed to protecting pharmacare. The Hill Times photograph by Andrew Meade
Opinion | BY BENOIT-ANTOINE BACON | November 5, 2025
Industry Minister Mélanie Joly is in charge of the research file. Universities, which contribute to economic growth, need sustained public investment in research and policies that foster long-term collaboration across sectors rather than short-term competition, writes Benoit-Antoine Bacon. The Hill Times photograph by Andrew Meade
Opinion | BY BENOIT-ANTOINE BACON | November 5, 2025
Opinion | BY BENOIT-ANTOINE BACON | November 5, 2025
Industry Minister Mélanie Joly is in charge of the research file. Universities, which contribute to economic growth, need sustained public investment in research and policies that foster long-term collaboration across sectors rather than short-term competition, writes Benoit-Antoine Bacon. The Hill Times photograph by Andrew Meade
News | BY TESSIE SANCI | November 3, 2025
The House health committee study was proposed by Conservative health critic Dan Mazier, left, who says there’s a ‘disconnect’ between immigration and the health care system. But Liberal MP Marcus Powlowski says the Conservatives’ framing of the issue ‘ticks’ him off and that the health-care system relies on immigrants who work within it. The Hill Times photographs by Andrew Meade
News | BY TESSIE SANCI | November 3, 2025
News | BY TESSIE SANCI | November 3, 2025
The House health committee study was proposed by Conservative health critic Dan Mazier, left, who says there’s a ‘disconnect’ between immigration and the health care system. But Liberal MP Marcus Powlowski says the Conservatives’ framing of the issue ‘ticks’ him off and that the health-care system relies on immigrants who work within it. The Hill Times photographs by Andrew Meade
News | BY TESSIE SANCI | October 27, 2025
Health Minister Marjorie Michel is named in 29 communication reports since joining cabinet in May. The Hill Times photograph by Andrew Meade
News | BY TESSIE SANCI | October 27, 2025
News | BY TESSIE SANCI | October 27, 2025
Health Minister Marjorie Michel is named in 29 communication reports since joining cabinet in May. The Hill Times photograph by Andrew Meade
Opinion | BY BHAGWANT SANDHU | April 15, 2024
Conservative Leader Pierre Poilievre, left, should pay attention to the costs wasted on drug prices in Canada, writes Bhagwant Sandhu. At least Green Party Leader Elizabeth May, centre, and NDP Leader Jagmeet Singh have pushed for a more cost-effective approach for Canadians.
Opinion | BY BHAGWANT SANDHU | April 15, 2024
Opinion | BY BHAGWANT SANDHU | April 15, 2024
Conservative Leader Pierre Poilievre, left, should pay attention to the costs wasted on drug prices in Canada, writes Bhagwant Sandhu. At least Green Party Leader Elizabeth May, centre, and NDP Leader Jagmeet Singh have pushed for a more cost-effective approach for Canadians.
Opinion | BY CATHY AMMENDOLEA | April 8, 2024
Mark Holland
We remain hopeful that pharmacare legislation, introduced on Feb. 29 by Health Minister Mark Holland, will rekindle Canadian values of affording people access to healthcare based on need, not ability to pay, writes Cathy Ammendolea. The Hill Times photograph by Andrew Meade
Opinion | BY CATHY AMMENDOLEA | April 8, 2024
Opinion | BY CATHY AMMENDOLEA | April 8, 2024
Mark Holland
We remain hopeful that pharmacare legislation, introduced on Feb. 29 by Health Minister Mark Holland, will rekindle Canadian values of affording people access to healthcare based on need, not ability to pay, writes Cathy Ammendolea. The Hill Times photograph by Andrew Meade
Opinion | April 8, 2024
Opinion | April 8, 2024
Opinion | April 8, 2024
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya
News | BY JESSE CNOCKAERT | April 1, 2024
Health Minister Mark Holland said Bill C-64 'will provide universal access to contraception and diabetes medication that will be transformational in improving health outcomes in Canada,' in a Health Canada press release on Feb. 29. The Hill Times photograph by Andrew Meade
News | BY JESSE CNOCKAERT | April 1, 2024
News | BY JESSE CNOCKAERT | April 1, 2024
Health Minister Mark Holland said Bill C-64 'will provide universal access to contraception and diabetes medication that will be transformational in improving health outcomes in Canada,' in a Health Canada press release on Feb. 29. The Hill Times photograph by Andrew Meade
Opinion | BY KRISTINA ACRI | March 14, 2024
If pharmacare becomes the law of the land, the 25 million Canadians who currently have private drug insurance plans will suddenly find themselves with significantly less coverage, writes Kristina Acri. Unsplash photograph by the National Cancer Institute
Opinion | BY KRISTINA ACRI | March 14, 2024
Opinion | BY KRISTINA ACRI | March 14, 2024
If pharmacare becomes the law of the land, the 25 million Canadians who currently have private drug insurance plans will suddenly find themselves with significantly less coverage, writes Kristina Acri. Unsplash photograph by the National Cancer Institute
Opinion | BY JAKE FUSS, MACKENZIE MOIR | February 28, 2024
Mark Holland
Health Minister Mark Holland and the Trudeau government have yet to explain to Canadians the true cost of its national pharmacare plan, write Jake Fuss and Mackenzie Moir. The Hill Times photograph by Andrew Meade
Opinion | BY JAKE FUSS, MACKENZIE MOIR | February 28, 2024
Opinion | BY JAKE FUSS, MACKENZIE MOIR | February 28, 2024
Mark Holland
Health Minister Mark Holland and the Trudeau government have yet to explain to Canadians the true cost of its national pharmacare plan, write Jake Fuss and Mackenzie Moir. The Hill Times photograph by Andrew Meade
Opinion | BY JASON WEIDA | February 5, 2024
Florida will only buy from a specific list of Canadian drugs that focus primarily on the treatment of mental health, prostate cancer, congenital genetic disorders, and HIV/AIDS for use only with specific populations, writes Jason Weida. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY JASON WEIDA | February 5, 2024
Opinion | BY JASON WEIDA | February 5, 2024
Florida will only buy from a specific list of Canadian drugs that focus primarily on the treatment of mental health, prostate cancer, congenital genetic disorders, and HIV/AIDS for use only with specific populations, writes Jason Weida. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
Opinion | BY STEVEN GLOBERMAN | January 10, 2024
U.S. Food and Drug Administration Commissioner Robert M. Califf, left, and Health Minister Mark Holland. Legalized importing of drugs from Canada into the U.S. could reduce the availability of drugs here, but not for the reasons you might think, writes Steven Globerman. Photograph courtesy of the U.S. FDA and The Hill Times photograph by Andrew Meade
News | BY JESSE CNOCKAERT | January 8, 2024
Prime Minister Justin Trudeau, left, and Conservative Leader Pierre Poilievre. More advocacy may be directed towards Conservative MPs this year in anticipation of a possible federal election and change in government, Tim Powers says. The Hill Times photographs by Andrew Meade
News | BY JESSE CNOCKAERT | January 8, 2024
News | BY JESSE CNOCKAERT | January 8, 2024
Prime Minister Justin Trudeau, left, and Conservative Leader Pierre Poilievre. More advocacy may be directed towards Conservative MPs this year in anticipation of a possible federal election and change in government, Tim Powers says. The Hill Times photographs by Andrew Meade
Opinion | BY STEVE MORGAN, MAEL HOUCK, HALEEMA AHMED | December 13, 2023
On Dec. 12, Health Minister Mark Holland, pictured, said his government is unlikely to pass pharmacare legislation by the end of the year—a deadline imposed by the NDP as a condition of the supply-and-confidence agreement between the two parties. The Hill Times photograph by Andrew Meade
Opinion | BY STEVE MORGAN, MAEL HOUCK, HALEEMA AHMED | December 13, 2023
Opinion | BY STEVE MORGAN, MAEL HOUCK, HALEEMA AHMED | December 13, 2023
On Dec. 12, Health Minister Mark Holland, pictured, said his government is unlikely to pass pharmacare legislation by the end of the year—a deadline imposed by the NDP as a condition of the supply-and-confidence agreement between the two parties. The Hill Times photograph by Andrew Meade
Opinion | BY JOEL LEXCHIN | November 29, 2023
Mark Holland
As Health Minister Mark Holland works out upcoming pharmacare legislation, Joel Lexchin lays out some questions that might give him a better idea of how Canadians really feel about pharmacare. The Hill Times photograph by Andrew Meade
Opinion | BY JOEL LEXCHIN | November 29, 2023
Opinion | BY JOEL LEXCHIN | November 29, 2023
Mark Holland
As Health Minister Mark Holland works out upcoming pharmacare legislation, Joel Lexchin lays out some questions that might give him a better idea of how Canadians really feel about pharmacare. The Hill Times photograph by Andrew Meade